|Medical Instruments & Supplies Market Industry|
|More Pages: Page: (1) |
| ||Nanosphere, Inc. develops, manufactures, and markets a molecular diagnostics platform, the Verigene System, that enables genomic and protein testing on a single platform. Its proprietary nanoparticle technology provides the ability to run multiple tests at the same time on the same sample, and enables the development of various test assays to be performed on a single platform. The company is developing diagnostic tests for a range of medical conditions, including cancer, neurodegenerative, cardiovascular, and infectious diseases, as well as pharmaco-genomics or tests for personalized medicine. It is also developing other genomic assays, including tests for cystic fibrosis and a range of infectious diseases. In addition, the company has a program to develop protein tests based on established biomarkers and to validate new biomarkers, in which its ultra-sensitive protein detection technology enables earlier detection of various diseases. Nanosphere was founded in 1998 and is headquartered in Northbrook, Illinois.|
| ||Market Cap||Day's Volume||Last Trade||Change|
|More Pages: Page: (1) ||
Investing by Industry or Market Sector employs non-emotional, numbers driven, value-based industry, sector, and country rotation techniques, that, unlike conventional stock picking methods, focuses instead on identifying and capitalizing on theme movements in the well identified industries & market sectors.
Primarily, this active-asset methodology recognizes that advances in financial markets are defined by "themes", or led by asset classes, industries, and countries, with each advance distinguished by specific sector-driven themes. Employing a disciplined research and valuation process these "themes" are identified so that Portfolio's can be created and/or adjusted toward the most attractive sectors.